Caprock Group LLC Invests $5.69 Million in HCA Healthcare, Inc. $HCA

Caprock Group LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 14,095 shares of the company’s stock, valued at approximately $5,694,000.

A number of other institutional investors also recently bought and sold shares of the stock. Brighton Jones LLC purchased a new stake in HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its holdings in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Concurrent Investment Advisors LLC raised its position in shares of HCA Healthcare by 4.3% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company’s stock valued at $856,000 after purchasing an additional 93 shares during the period. Finally, CWM LLC increased its stake in HCA Healthcare by 5.4% in the 2nd quarter. CWM LLC now owns 13,062 shares of the company’s stock worth $5,004,000 after buying an additional 667 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $530.95 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $534.59. The firm has a market capitalization of $121.16 billion, a PE ratio of 18.71, a PEG ratio of 1.54 and a beta of 1.36. The stock’s fifty day moving average is $480.78 and its 200 day moving average is $446.23.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised multiple near‑ and long‑term EPS forecasts for HCA (Q2–Q4 2026, several quarters in 2027, FY2027 and FY2028), boosting modeled future profitability even though Zacks retains a “Hold” rating — this analyst upgrade is a primary driver of the stock move.
• Positive Sentiment: HCA’s outpatient expansion continues to reshape its care network, increasing lower‑cost, higher‑margin ambulatory volumes that can lift revenue growth and operating margins over time. HCA’s outpatient boom reshapes its care network
• Positive Sentiment: StoneSprings Hospital Center plans to convert a deli into a freestanding ER in Chantilly — a localized capacity expansion to capture ED volume and downstream admissions/surgeries, signaling continued investment in site-of-care growth. HCA’s StoneSprings Hospital Center looks to turn Chantilly deli into freestanding ER
• Neutral Sentiment: HCA ASC real estate was sold — this monetizes noncore assets and can free cash (positive) but may imply sale‑leaseback obligations (costs) depending on terms; impact depends on deal structure and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: An HCA veteran has taken a COO role at Memorial Health (Georgia/Florida reports) — routine executive movement that highlights HCA’s management bench but likely has limited direct impact on HCA’s near‑term results. Former HCA Florida executive joins Memorial Health as COO HCA veteran named COO of Memorial Health in Georgia
• Neutral Sentiment: Other local developments and community activity (interfacility transport partnerships, Habitat build, internal nursing leadership moves) are operational/CSR items that support reputation and network functioning but are unlikely to move earnings materially in the near term. AmeriPro Health expands Fla. operations with new interfacility transport partnership HCA Healthcare leaders join Habitat build in Dorchester County HCA Missouri hospital taps chief nurse

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. The Goldman Sachs Group lifted their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. UBS Group raised their target price on shares of HCA Healthcare from $525.00 to $598.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Stephens increased their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $523.27.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.